Penn Comprehensive Neuroscience Center >
- Faculty
| Home |  |
About the Center | |
Faculty Members | |
Patient Care | |
Education and Training | |
Research and Clinical Trials |
Faculty Members: 
Murray Grossman, M.D., Ed.D.
Professor of Neurology
Department: Neurology
Contact information
HUP
3400 SPRUCE ST.
4283
Philadelphia, PA 19104
3400 SPRUCE ST.
4283
Philadelphia, PA 19104
Office: 2156623361
Graduate Group Affiliations
Education:
B.A. (Psych/Soc/Engl)
Union College, 1972.
MEd (Special Education)
Boston University, 1973.
Ed.D. (Neuropsychology)
Boston University, 1977.
M.D. (Medicine)
McGill University, 1985.
B.A. (Psych/Soc/Engl)
Union College, 1972.
MEd (Special Education)
Boston University, 1973.
Ed.D. (Neuropsychology)
Boston University, 1977.
M.D. (Medicine)
McGill University, 1985.
Post-Graduate Training
Fellowship, Psycholinguistics, MIT, Cambridge, MA, 1977-1979.
Intern, Medicine, Royal Victoria Hospital, Montreal, Canada, 1985-1986.
Resident, Neurology, Hospital of the University of Pennsylvania, Philadelphia, 1986-1989.
Fellowship, Psycholinguistics, MIT, Cambridge, MA, 1977-1979.
Intern, Medicine, Royal Victoria Hospital, Montreal, Canada, 1985-1986.
Resident, Neurology, Hospital of the University of Pennsylvania, Philadelphia, 1986-1989.
Certifications
American Board of Psychiatry and Neurology (#33512), 1991.
Permanent linkAmerican Board of Psychiatry and Neurology (#33512), 1991.
Description of Research Expertise
RESEARCH INTERESTS: Biomarker studies in neurodegenerative diseases.KEY WORDS: frontotemporal degeneration, neurolinguistics, social disorders, executive functioning, neuroimaging, cerebrospinal fluid, plasma, genetics
DESCRIPTION OF RESEARCH: We assess behavioral, imaging and biofluid measures in patients with frontotemporal degeneration spectrum disorders, including primary progressive aphasia, behavioral variant FTD, amyotrophic lateral sclerosis, corticobasal degeneration and progressive supranuclear palsy. We also study parkinson spectrum disorders. The goal is to identify the best set of behavioral, neuroimaging and biofluid measures that reflect the underlying proteinopathy in each of these patient groups. We participate in clinical treatment trials.
Description of Clinical Expertise
Young-onset neurodegenerative conditions including frontotemporal degeneration spectrum disorders such as primary progressive aphasia and behavioral variant frontotemporal degeneration, parkinson spectrum disorders such as Parkinson's disease and Lewy body disease, corticobasal degeneration and progressive supranuclear palsy, and amyotrophic lateral sclerosis.Description of Other Expertise
Director, Penn Frontotemporal Degeneration Center
